Key Responsibilities Continuous Improvement & Operational Excellence Lead the deployment and continuous improvement of the CSL Operating System (COS) within Value Stream Bulk. Develop, manage, and execute the CI roadmap and portfolio, including project identification, business case development, prioritization, milestone planning, benefit tracking, and reporting. Identify and implement improvement opportunities to strengthen compliance, quality, efficiency, delivery performance, and process reliability. Lead and facilitate Kaizen events, Lean/Six Sigma initiatives, structured problem-solving workshops, and cross-functional improvement projects. Performance Management & COS Reporting Drive KPI governance and performance management through COS-based reporting, dashboarding, visual management, and performance review routines. Conduct trend analyses and translate performance insights into prioritized improvement actions. Ensure transparency, standardization, and data integrity of performance reporting in alignment with CSL standards and business objectives. Monitor and communicate the impact of improvement initiatives through KPI improvement and benefit realization tracking. Process Optimization & Change Leadership Drive process optimization, standardization, and digitalization initiatives across manufacturing and supporting functions. Coach leaders and employees in Lean Thinking, Operational Excellence principles, Visual Management, and structured problem solving. Act as a change agent to foster a culture of accountability, continuous improvement, and operational excellence. Ensure successful implementation of improvement initiatives on time, within budget, and with sustainable results.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients’ needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives. CSL Behring operates one of the world’s largest plasma collection networks, CSL Plasma. Our parent company, CSL, headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. To learn more about CSL, CSL Behring, CSL Seqirus and CSL Vifor visit https://www.csl.com/ and CSL Plasma at https://www.cslplasma.com/.
